The final, formatted version of the article will be published soon.
SYSTEMATIC REVIEW article
Front. Nutr.
Sec. Nutrition and Metabolism
Volume 12 - 2025 |
doi: 10.3389/fnut.2025.1502815
This article is part of the Research Topic Micronutrients and Metabolic Diseases-Volume II View all 10 articles
Evaluating the Effects of Seed Oils on Lipid Profile, Inflammatory and Oxidative Markers, and Glycemic Control of Diabetic and Dyslipidemic Patients: A Systematic Review of Clinical Studies
Provisionally accepted- 1 Medical School of Marilia, Marília, Brazil
- 2 Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil
- 3 Universidade de Marília, Marilia, Sao Paulo, Brazil
- 4 Research Institute for Medicines (iMed.ULisboa), Lisboa, Lisboa, Portugal
Diabetes mellitus and dyslipidemia are significant health concerns that elevate the risk of cardiovascular disease and other metabolic disorders, necessitating effective management strategies.Recent research has highlighted the potential role of dietary fats, particularly seed oils, in influencing health outcomes in these conditions. This systematic review evaluates the impact of seed oils on lipid profiles, inflammatory and oxidative markers, and glycemic control in patients with diabetes and dyslipidemia. A comprehensive search across databases, including PubMed, Scopus, Web of Science, Cochrane Library, and Google Scholar, identified studies focusing on the effects of seed oils. The studies include randomized controlled, parallel-design, double-blind, placebo-controlled, and openlabel studies published in English. The quality of the studies was assessed through a detailed review process, and data were extracted to evaluate the effects of seed oils on key metabolic markers. The review included 11 studies demonstrating that seed oils derived from canola, flaxseed, and sesame seeds can positively influence lipid profiles and glycemic control while potentially modulating oxidative stress markers. The findings suggest that seed oils may benefit in managing diabetes and dyslipidemia, although the results are sometimes inconsistent. This review provides valuable insights for dietary recommendations and therapeutic strategies, highlighting the need for further research to clarify the role of seed oils in metabolic health.
Keywords: Seed oils, Dyslipidemia, type 2 diabetes, Lipid profiles, Inflammatory markers, glycemic control, clinical trials, Cardiometabolic Health
Received: 27 Sep 2024; Accepted: 13 Jan 2025.
Copyright: © 2025 FORNARI LAURINDO, Fornari Laurindo, Dogani Rodrigues, da Silva Camarinha Oliveira, Leme Boaro, Cressoni Araújo, Landgraf Guiguer, Rucco Penteado Detregiachi, Maria Cavallari Strozze Catharin, Federighi Baisi Chagas, Cavallari Strozze Catharin, Direito and Barbalho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
LUCAS FORNARI LAURINDO, Medical School of Marilia, Marília, Brazil
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.